Remdesivir against COVID-19 and other viral diseases
JJ Malin, I Suárez, V Priesner… - Clinical microbiology …, 2020 - Am Soc Microbiol
Patients and physicians worldwide are facing tremendous health care hazards that are
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS …
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS …
[HTML][HTML] Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
CA Morales-Paredes, JM Rodríguez-Díaz… - Science of the Total …, 2022 - Elsevier
During the COVID-19 pandemic, high consumption of antivirals, antibiotics, antiparasitics,
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …
antiprotozoals, and glucocorticoids used in the treatment of this virus has been reported …
[HTML][HTML] Remdesivir for the treatment of COVID‐19
F Grundeis, K Ansems, K Dahms… - … of systematic reviews, 2023 - ncbi.nlm.nih.gov
Background Remdesivir is an antiviral medicine approved for the treatment of mild‐to‐
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …
Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis
E Karakike, EJ Giamarellos-Bourboulis… - Critical care …, 2021 - journals.lww.com
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …
respiratory tract infection, which can induce respiratory failure and multiple organ …
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
ABSTRACT Introduction: The current SARS-CoV-2 pandemic urgently demands for both
prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has …
prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has …
An overview on the treatments and prevention against COVID-19
Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global health
crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as …
crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as …
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
HXJ Lin, S Cho, V Meyyur Aravamudan, HY Sanda… - Infection, 2021 - Springer
COVID-19 is an infectious disease caused by a novel β-coronavirus, belonging to the same
subgenus as the Severe Acute Respiratory Syndrome (SARS) virus. Remdesivir, an …
subgenus as the Severe Acute Respiratory Syndrome (SARS) virus. Remdesivir, an …
Prenatal exposure to perfluoroalkyl substances associated with increased susceptibility to liver injury in children
The severe acute respiratory syndrome coronavirus 2 pandemic has drastically altered all
facets of clinical care and research. Clinical research in hepatology has had a rich tradition …
facets of clinical care and research. Clinical research in hepatology has had a rich tradition …
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis
Background Acute kidney injury (AKI) can affect hospitalized patients with coronavirus
disease 2019 (COVID-19), with estimates ranging between 0.5% and 40%. We performed a …
disease 2019 (COVID-19), with estimates ranging between 0.5% and 40%. We performed a …